DIH Holdings US Stock Price, News & Analysis

DIH Holding US, Inc. (NASDAQ: DHAI) is a healthcare company in the medical devices industry that focuses on physical rehabilitation technologies. According to company disclosures, DIH describes its name as standing for a vision to “Deliver Inspiration & Health,” with the stated goal of improving the daily lives of people with disabilities and functional impairments. The company positions itself as a global provider of advanced robotic devices used in rehabilitation settings.

DIH reports that its rehabilitation devices incorporate robotics and visual stimulation in an interactive manner. These systems are designed to support clinical research and intensive functional rehabilitation and training for patients with walking impairments, reduced balance, and impaired arm and hand functions. The company presents itself as addressing a largely fragmented and manual-labor-driven rehabilitation industry by offering technology-enabled rehabilitation solutions.

Business focus and technology

Based on its public statements, DIH’s core business centers on advanced robotic devices for physical rehabilitation. The company states that its devices enable intensive, repetitive training that can be important for patients recovering mobility or functional use of limbs. Visual stimulation and interactive feedback are highlighted as integral parts of DIH’s approach, intended to engage patients and support clinical protocols.

DIH notes that it has been built through the mergers of niche technology providers in rehabilitation, describing itself as a consolidator in its segment. The company has also referenced software-related initiatives, including capitalized software associated with its HocoNet platform, although it disclosed that it ceased further development of that capitalized software and discontinued development and commercialization of its SafeGait product during its fiscal year ended March 31, 2025, resulting in impairment losses.

Rehabilitation applications

In its public materials, DIH emphasizes applications for patients with:

• Walking impairments
• Reduced balance
• Impaired arm and hand functions

The company states that its devices are used both for intensive rehabilitation and clinical research, indicating a focus on clinical environments where objective, technology-assisted training and measurement are important.

Capital markets and listing history

DIH Holding US, Inc. has been listed on the Nasdaq Stock Market under the symbol DHAI. The company disclosed that its Class A common stock underwent a 1-for-25 reverse stock split. A certificate of amendment to its certificate of incorporation was filed in Delaware to effect this reverse stock split, and the company reported that its common stock began trading on a split-adjusted basis on the Nasdaq Stock Market on October 20, 2025, under the existing symbol DHAI. DIH stated that the reverse stock split did not change the par value or the authorized number of shares of its common or preferred stock.

In multiple press releases and SEC filings, DIH has reported receiving several notices from Nasdaq’s Listing Qualifications Staff regarding continued listing requirements, including matters related to market value of listed securities, market value of publicly held shares, bid price, and timely filing of periodic reports. The company sought a hearing before a Nasdaq Hearings Panel to present its plan to address these issues and requested stays of delisting actions while that process was underway.

Delisting from Nasdaq and trading status

On November 5, 2025, DIH reported receiving a determination letter from Nasdaq indicating that the Nasdaq Hearings Panel had denied the company’s request to continue its listing. The company disclosed that, as a result, its shares would be delisted from Nasdaq and that trading in its securities would be suspended at the open of trading on November 7, 2025. DIH further stated that it did not intend to request review of the Panel’s decision by the Nasdaq Listing and Hearing Review Council.

In the same SEC filing, DIH explained that, as a result of the suspension in trading and delisting, there may be a very limited market in which its shares are traded. The company stated that it intended to have its securities quoted in the over-the-counter market under the same symbols, but cautioned that stockholders might find it difficult to sell their shares and that any trading price could be adversely affected.

Liquidity, going concern, and operational status

DIH’s public filings have discussed its capital structure and financing arrangements, including senior secured convertible debentures and an equity line of credit with an investor. The company described terms such as original-issue-discount debentures, conversion prices, monthly redemption mechanics, and warrants, as well as shareholder approvals related to potential share issuances and adjustments to conversion prices.

In the November 6, 2025 Form 8-K, DIH stated that, as previously disclosed in its public filings, the company and its auditors believed there was substantial doubt about its ability to continue as a going concern. It further disclosed that, as a result of the Nasdaq delisting and the conclusion that sources of additional capital needed to fund day-to-day operations would be unavailable, the company had determined to suspend its operations while it evaluates strategic alternatives.

Leadership changes

DIH has reported several changes in its governance and leadership. The company announced the appointments of new independent directors to its Board, including individuals with backgrounds in healthcare finance, operations, and technology. In later filings, DIH reported that Jason Chen, then serving as Chief Executive Officer, notified the Board on November 24, 2025 that he was resigning from his position as CEO and from similar positions at subsidiaries, effective immediately. A subsequent filing noted that on December 15, 2025 he also resigned as a member of the Board and from all committee memberships.

Company status and historical context

Based on the SEC filings provided, DIH Holding US, Inc. remains a reporting company but has experienced delisting from Nasdaq, liquidity constraints, and suspension of operations. The company has described itself as evaluating strategic alternatives in light of these circumstances. For investors and observers, DIH’s disclosures provide historical context on its business focus in rehabilitation robotics, its capital structure and financing efforts, and the regulatory and listing challenges it has faced.